Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorcaserin for Weight Gain Prevention in Smoking Cessation
NCT02412631Phase 3Terminated
- Sponsor
- Mayo Clinic
- Start
- Jun 2016
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lorcaserin in obesity, sponsored by Mayo Clinic. Started Jun 2016; status: terminated.
02
Drugs
lorcaserin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02412631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02412631.